BaillieJAnagnostouDSivellS, et al. Symptom management, nutrition and hydration at end-of-life: a qualitative exploration of patients’, carers’ and health professionals’ experiences and further research questions. BMC Palliat Care2018; 17: 60.
2.
CampbellRMcCaffreyNBrownL, et al. Clinician-reported changes in octreotide prescribing for malignant bowel obstruction as a result of an adequately powered phase III study: a transnational, online survey. Palliat Med2018; 32:1363–1368.
3.
StarABolandJW.Updates in palliative care - recent advancements in the pharmacological management of symptoms. Clin Med2018; 18:11–16.
BolandJWLawlorPGBushSH.Delirium: non-pharmacological and pharmacological management. BMJ Support Palliat Care2019; 9:482–484.
6.
FinucaneAMJonesLLeurentB, et al. Drug therapy for delirium in terminally ill adults. Cochrane Database Syst Rev2020; 1: CD004770.
7.
BolandJWBolandEG.Pharmacological therapies for opioid induced constipation in adults with cancer. BMJ2017; 358: j3313.
8.
ChapmanEJEdwardsZBolandJW, et al. Practice review: evidence-based and effective management of pain in patients with advanced cancer. Palliat Med2020; 34: 444–453.
9.
CurrowDCGlarePLouwS, et al. A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer. Sci Rep2021; 11:2421.
10.
ObitaGPBolandEGCurrowDC, et al. Somatostatin analogues compared with placebo and other pharmacologic agents in the management of symptoms of inoperable malignant bowel obstruction: a systematic review. J Pain Symptom Manag2016; 52: 901–919.e1.
11.
BolandJWBolandEG.Malignant bowel obstruction. In: ChernyNFallonMTKaasaS, et al. (eds) Oxford textbook of palliative medicine. 6th ed.Oxford: Oxford University Press, 2021, pp.904–917.
12.
BaddeleyEMannMBravingtonA, et al. Symptom burden and lived experiences of patients, caregivers and healthcare professionals on the management of malignant bowel obstruction: a qualitative systematic review. Palliat Med. Epub ahead of print 8 March 2022. DOI: 10.1177/02692163221081331.
13.
Razmovski-NaumovskiVLuckettTAmgarth-DuffI, et al. Efficacy of medicinal cannabis for appetite-related symptoms in people with cancer: a systematic review. Palliat Med. Epub ahead of print 31 Mar 2022. DOI: 10.1177/02692163221083437.
14.
HusseinADiggesMChangS, et al. Pharmacovigilance in hospice/palliative care: net effect of amitriptyline or nortriptyline on neuropathic pain: UTS/IMPACCT Rapid programme international consecutive cohort. Palliat Med. Epub ahead of print 10 April 2022. DOI: 10.1177/02692163221085855.
15.
BolandEGBennettMIAllgarV, et al. Cannabinoids for adult cancer-related pain: systematic review and meta-analysis. BMJ Support Palliat Care2020; 10:14–24.
16.
DiggesMHusseinAWilcockA, et al. Pharmacovigilance in hospice/palliative care: net effect of haloperidol for nausea or vomiting. J Palliat Med2018; 21:37–43.
17.
BaddeleyEBravingtonAJohnsonM, et al. Development of a core outcome set to use in the research and assessment of malignant bowel obstruction: protocol for the RAMBO study. BMJ Open2020; 10: e039154.
18.
BolandJCurrowDCWilcockA, et al. A systematic review of strategies used to increase recruitment of people with cancer or organ failure into clinical trials: implications for palliative care research. J Pain Symptom Manag2015; 49: 762–772.e5.
